NCT06506448View on ClinicalTrials.gov

Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

January 31, 2029

Conditions
ST Elevation Myocardial Infarction
Interventions
DIAGNOSTIC_TEST

CT Coronary Angiography

CTCA for anatomical, physiological, plaque composition and inflammatory assessment of coronary arteries

Trial Locations (3)

BH15 2JB

RECRUITING

University Hospitals Dorset NHS Foundation Trust, Bournemouth

SO16 6YD

RECRUITING

University Hospital Southampton NHS Foundation Trust, Southampton

ST4 6QG

RECRUITING

Royal Stoke University Hospital, Stoke-on-Trent

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

HeartFlow, Inc.

INDUSTRY

collaborator

Wessex Heartbeat

UNKNOWN

collaborator

Caristo

UNKNOWN

lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT06506448 - Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease | Biotech Hunter | Biotech Hunter